Pre-Market
PRLD
Prelude Therapeutics Inc
NASDAQ HEALTHCARE
$3.43
+$0.07 (+2.08%)
Delayed 15 min · Mar 18, 5:38 AM UTC
Open
$3.40
High
$3.60
Low
$3.37
Prev Close
$3.36
Volume
138.98K

Price Chart

About Prelude Therapeutics Inc

Prelude Therapeutics Incorporated, a precision clinical-stage oncology company, focuses on the discovery and development of small molecule therapies optimized to target key drivers in cancers. The company is headquartered in Wilmington, Delaware.

PRLD News

No recent news available for PRLD

💬 Discussion

Loading...
Loading comments...